Breakdown |
---|
Income Statement |
Total Revenue |
Gross Profit |
EBITDA |
Net Income |
Balance Sheet |
Total Assets |
Cash, Cash Equivalents and Short-Term Investments |
Total Debt |
Total Liabilities |
Stockholders Equity |
Cash Flow |
Free Cash Flow |
Operating Cash Flow |
Investing Cash Flow |
Financing Cash Flow |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
62 Neutral | $17.27B | 9.98 | -8.46% | 3.12% | 1.63% | -26.06% | |
56 Neutral | $9.60M | 7.11 | 23.48% | ― | 12.93% | 66.81% | |
47 Neutral | $5.84M | ― | -797.66% | ― | 1.33% | 35.82% | |
40 Neutral | $5.91M | ― | -11.87% | ― | -25.81% | 85.84% | |
37 Underperform | $4.22M | ― | -809.91% | ― | -10.59% | 99.33% |
On June 5, 2025, Inspire Veterinary Partners, Inc. completed the acquisition of Debary Animal Clinic and its related real estate assets in Florida, marking its fifth acquisition in the state. This acquisition is expected to add approximately $1.8 million in annual revenue and increase the company’s network of animal hospitals to 14, enhancing its presence in the Florida pet care market.
On May 30, 2025, Inspire Veterinary Partners, Inc. issued Original Issue Discount Notes to 1800 Diagonal Lending LLC and Boot Capital LLC, with principal amounts of $204,700 and $92,000 respectively, to be used for general working capital. These notes, which mature on March 30, 2026, include provisions for interest payments and allow the lenders to convert the debt into shares of the company’s common stock under certain conditions, impacting the company’s financial strategy and stakeholder interests.